Abstract
Introduction: Testicular germ cell tumor is a rare malignant tumor predominantly affecting young males. In addition to well-established risk factors like cryptorchidism, genetic factors are increasingly recognized as significant contributors. This case report highlights a patient diagnosed with seminoma associated with multiple abnormalities and explores the genetic basis behind these manifestations. Case Presentation: A 22-year-old East Asian male presented with left-sided varicocele and recent onset testicular pain. Clinical examination and imaging revealed a smaller left testicle and a testicular nodule. Surgical excision and subsequent histopathology confirmed seminoma and germ cell neoplasia in situ. Additional medical investigations identified brain dysplasia, social interaction challenges, learning impairments, and a presacral mass suggestive of teratoma. Genetic analysis using exome sequencing detected a frameshift variant in the PDE11A gene, predicted by AlphaFold3 to significantly disrupt protein structure and function. The patient later underwent orchiectomy following recurrence confirmation. Conclusion: This report emphasizes the potential pathogenic role of the PDE11A frameshift variant in seminoma development and associated systemic abnormalities. The application of advanced computational tools like AlphaFold3 can provide deeper molecular insights into genetic variants and further elucidate their clinical implications.
Journal Section:
Case Report
References
1.
Wu
X
, Groves
FD
, McLaughlin
CC
, Jemal
A
, Martin
J
, Chen
VW
. Cancer incidence patterns among adolescents and young adults in the United States
. Cancer Causes Control
. 2005
;16
(3
):309
–20
. 2.
Siegel
RL
, Miller
KD
, Jemal
A
. Cancer statistics
. CA Cancer J Clin
. 2018
;68
(1
):7
–30
. 3.
Oldenburg
J
, Fosså
SD
, Nuver
J
, Heidenreich
A
, Schmoll
HJ
, Bokemeyer
C
, et al. Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
. Ann Oncol
. 2013
;24
(Suppl 6
):vi125
–32
. 4.
Huyghe
E
, Matsuda
T
, Thonneau
P
. Increasing incidence of testicular cancer worldwide: a review
. J Urol
. 2003
;170
(1
):5
–11
. 5.
Purdue
MP
, Devesa
SS
, Sigurdson
AJ
, McGlynn
KA
. International patterns and trends in testis cancer incidence
. Int J Cancer
. 2005
;115
(5
):822
–7
. 6.
Dieckmann
KP
, Pichlmeier
U
. Clinical epidemiology of testicular germ cell tumors
. World J Urol
. 2004
;22
(1
):2
–14
. 7.
Swerdlow
AJ
, Higgins
CD
, Pike
MC
. Risk of testicular cancer in cohort of boys with cryptorchidism
. BMJ
. 1997
;314
(7093
):1507
–11
. 8.
Hardell
L
, Ohlson
CG
, Fredrikson
M
. Occupational exposure to polyvinyl chloride as a risk factor for testicular cancer evaluated in a case-control study
. Int J Cancer
. 1997
;73
(6
):828
–30
. 9.
Greene
MH
, Kratz
CP
, Mai
PL
, Mueller
C
, Peters
JA
, Bratslavsky
G
, et al. Familial testicular germ cell tumors in adults: 2010 summary of genetic risk factors and clinical phenotype
. Endocr Relat Cancer
. 2010
;17
(2
):R109
–21
. 10.
Horvath
A
, Korde
L
, Greene
MH
, Libe
R
, Osorio
P
, Faucz
FR
, et al. Functional phosphodiesterase 11A mutations may modify the risk of familial and bilateral testicular germ cell tumors
. Cancer Res
. 2009
;69
(13
):5301
–6
. 11.
Qin
W
, Zhou
A
, Zuo
X
, Jia
L
, Li
F
, Wang
Q
, et al. Exome sequencing revealed PDE11A as a novel candidate gene for early-onset Alzheimer’s disease
. Hum Mol Genet
. 2021
;30
(9
):811
–22
. 12.
Abramson
J
, Adler
J
, Dunger
J
, Evans
R
, Green
T
, Pritzel
A
, et al. Addendum: accurate structure prediction of biomolecular interactions with AlphaFold 3
. Nature
. 2024
;636
(8042
):E4
. 13.
Pathak
A
, Stewart
DR
, Faucz
FR
, Xekouki
P
, Bass
S
, Vogt
A
, et al. Rare inactivating PDE11A variants associated with testicular germ cell tumors
. Endocr Relat Cancer
. 2015
;22
(6
):909
–17
. 14.
Azevedo
MF
, Horvath
A
, Bornstein
ER
, Almeida
MQ
, Xekouki
P
, Faucz
FR
, et al. Cyclic AMP and c-KIT signaling in familial testicular germ cell tumor predisposition
. J Clin Endocrinol Metab
. 2013
;98
(8
):E1393
–400
. 15.
Wayman
C
, Phillips
S
, Lunny
C
, Webb
T
, Fawcett
L
, Baxendale
R
, et al. Phosphodiesterase 11 (PDE11) regulation of spermatozoa physiology
. Int J Impot Res
. 2005
;17
(3
):216
–23
. 16.
Faja
F
, Finocchi
F
, Carlini
T
, Rizzo
F
, Pallotti
F
, Spaziani
M
, et al. PDE11A gene polymorphism in testicular cancer: sperm parameters and hormonal profile
. J Endocrinol Investig
. 2021
;44
(10
):2273
–84
. 17.
Oosterhuis
JW
, Looijenga
LHJ
. Human germ cell tumours from a developmental perspective
. Nat Rev Cancer
. 2019
;19
(9
):522
–37
. 18.
Phi
JH
. Sacrococcygeal teratoma: a tumor at the center of embryogenesis
. J Korean Neurosurg Soc
. 2021
;64
(3
):406
–13
. 19.
Greene
MH
, Mai
PL
, Loud
JT
, Pathak
A
, Peters
JA
, Mirabello
L
, et al. Familial testicular germ cell tumors (FTGCT): overview of a multidisciplinary etiologic study
. Andrology
. 2015
;3
(1
):47
–58
. 20.
Kelly
MP
, Logue
SF
, Brennan
J
, Day
JP
, Lakkaraju
S
, Jiang
L
, et al. Phosphodiesterase 11A in brain is enriched in ventral hippocampus and deletion causes psychiatric disease-related phenotypes
. Proc Natl Acad Sci U S A
. 2010
;107
(18
):8457
–62
. 21.
Shenton
ME
, Dickey
CC
, Frumin
M
, McCarley
RW
. A review of MRI findings in schizophrenia
. Schizophr Res
. 2001
;49
(1–2
):1
–52
. 22.
Pilarzyk
K
, Klett
J
, Pena
EA
, Porcher
L
, Smith
AJ
, Kelly
MP
. Loss of function of phosphodiesterase 11A4 shows that recent and remote long-term memories can Be uncoupled
. Curr Biol
. 2019
;29
(14
):2307
–21.e5
. 23.
Kelly
MP
. A role for phosphodiesterase 11A (PDE11A) in the formation of social memories and the stabilization of mood
. Adv Neurobiol
. 2017
;17
:201
–30
. 24.
Hegde
S
, Capell
WR
, Ibrahim
BA
, Klett
J
, Patel
NS
, Sougiannis
AT
, et al. Phosphodiesterase 11A (PDE11A), enriched in ventral Hippocampus neurons, is required for consolidation of social but not nonsocial memories in mice
. Neuropsychopharmacology
. 2016
;41
(12
):2920
–31
. 25.
Sharpe
RM
, Skakkebaek
NE
. Testicular dysgenesis syndrome: mechanistic insights and potential new downstream effects
. Fertil Steril
. 2008
;89
(2 Suppl
):e33
–8
. 26.
Kahn
LG
, Philippat
C
, Nakayama
SF
, Slama
R
, Trasande
L
. Endocrine-disrupting chemicals: implications for human health
. Lancet Diabetes Endocrinol
. 2020
;8
(8
):703
–18
. 27.
Yang
TC
, Jovanovic
N
, Chong
F
, Worcester
M
, Sakhi
AK
, Thomsen
C
, et al. Interventions to reduce exposure to synthetic phenols and phthalates from dietary intake and personal care products: a scoping review
. Curr Environ Health Rep
. 2023
;10
(2
):184
–214
. 28.
Mínguez-Alarcón
L
, Gaskins
AJ
, Meeker
JD
, Braun
JM
, Chavarro
JE
. Endocrine-disrupting chemicals and male reproductive health
. Fertil Steril
. 2023
;120
(6
):1138
–49
. © 2025 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2025
You do not currently have access to this content.
